U.S. FDA to reconsider decision barring compounded versions of Lilly weight loss drug
Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain.Cristina Arias | Cover | Getty ImagesThe U.S. Food and ...
Tag: Novo Nordisk A/S
Morgan Stanley’s Slimmon says U.S. infrastructure is ‘very powerful’
Stocks in the infrastructure sector aren't always top of mind. When it comes to investing, tech stocks like chipmaker Nvidia ...
Blockbuster weight-loss drug supply hit in trade shutdown
An Eli Lilly & Co. Zepbound injection pen, March 28, 2024.Bloomberg | Bloomberg | Getty ImagesAs a port strike stretching ...
East Coast ports strike, ILA union work stop strands billions in trade
Shipping containers sit stacked in the Port of Newark on September 30, 2024 seen from New York City. A massive ...
Novo Nordisk CEO to testify at Senate over weight loss drug prices
Lars Fruergaard Jørgensen, CEO of Novo Nordisk, speaks during an interview in New York on Aug. 10, 2022.Christopher Goodney | ...
FTC sues drug middlemen for allegedly inflating insulin prices
Lina Khan, Chair of the Federal Trade Commission (FTC), testifies before the House Appropriations Subcommittee at the Rayburn House Office ...
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
The CEO of Novartis said Wednesday that the Swiss pharmaceutical giant does not plan to enter into the "frenzy" of ...
JPMorgan says this new player in the GLP-1 market could rally 45%
JPMorgan thinks Viking Therapeutics could be the next big name in the GLP-1 boom. The firm initiated coverage of the ...
Welcome to LJ News Opinions, where breaking news stories have captivated us for over 20 years.
Join us in this journey of sharing points of view about the news – read, react, engage, and unleash your opinion!